Precision medicine won’t change healthcare, but governance could

• A review by more than 40 experts recently found that precision medicine’s key barriers exist in policy and governance, not science and technology.
• Unlocking data, prioritizing inclusivity and rethinking pricing models are key to maximizing precision medicine’s full potential.

Could precision medicine see a resurgence in the post-COVID era? Not without fixing longstanding policy and governance challenges like cross-border data access, ethical technology development, genomic data policies and viability of diagnostics development.

That was the message from more than 40 global experts from across the healthcare ecosystem recently. They took a hard look at the barriers standing in the way of precision medicine approaches over the last 12 months part of the World...

Today's Sponsors

Today's Sponsor